Medical device company ICU Medical (NASDAQ:ICUI) will be announcing earnings results this Thursday after market close. Here’s what to expect. ICU Medical beat analysts’ revenue expectations by 5.7% ...

As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...

In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.

View ICU Medical, Inc. ICUI stock quote prices, financial information, real-time forecasts, and company news from CNN.

ICU Medical beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $589.1 million, up 6.5% year on year. It was a mixed quarter for the company, with an impressive beat of ...

ICU Medical’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $186.40 (compared to the current share price of $134.32).

So unless ICU Medical Inc sees its shares decline 20% and the contract is exercised (resulting in a cost basis of $131.80 per share before broker commissions, subtracting the $8.20 from $140), the ...

ICU Medical will acquire Smiths Medical for around $2.3 billion in cash and stock. The terms include $1.85 billion in cash, 2.5 million new shares, and a $100 million earn-out based on ICU Medical ...

ICU Medical Inc. shares fell 22% after the San Clemente company said fourth-quarter sales of its medical devices were lower than analysts expected.